A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

ישראלמגייס משתתפיםPHASE3

מצבים רפואיים

Breast Neoplasms

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Ironwood Cancer & Research Centers ( Site 0066), Chandler, Arizona, United States

    Study coordinator · 480-821-2838
  • Banner MD Anderson Cancer Center-Oncology ( Site 0004), Gilbert, Arizona, United States

    Study coordinator · 480-256-6444
  • Providence Medical Foundation-Oncology ( Site 0020), Fullerton, California, United States

    Study coordinator · 714-446-5900
  • Moores Cancer Center ( Site 0059), La Jolla, California, United States

  • Cancer and Blood Specialty Clinic ( Site 0001), Los Alamitos, California, United States

    Study coordinator · 562-353-1200
  • University of Colorado Anschutz Medical Campus ( Site 0061), Aurora, Colorado, United States

    Study coordinator · 303-724-6077
  • UCHealth Cherry Creek Medical Center ( Site 0094), Denver, Colorado, United States

    Study coordinator · 720-848-1030
  • University of Colorado Health - Highlands Ranch Hospital ( Site 0095), Highlands Ranch, Colorado, United States

    Study coordinator · 720-848-1030
  • Yale Cancer Center ( Site 0060), New Haven, Connecticut, United States

    Study coordinator · 203-688-4242
  • Stamford Hospital ( Site 0049), Stamford, Connecticut, United States

    Study coordinator · 203-276-1000
  • AdventHealth Altamonte Springs ( Site 0021), Altamonte Springs, Florida, United States

    Study coordinator · 407-834-5151
  • University of Florida College of Medicine ( Site 0063), Gainesville, Florida, United States

    Study coordinator · 352-265-0725
  • Orlando Health Cancer Institute ( Site 0011), Orlando, Florida, United States

    Study coordinator · 321-843-8370
  • Archbold Memorial Hospital-Lewis Hall Singletary Oncology Center ( Site 0032), Thomasville, Georgia, United States

    Study coordinator · 229-584-5400
  • Rush University Medical Center ( Site 0079), Chicago, Illinois, United States

    Study coordinator · 312-942-3498
  • University of Chicago Medical Center ( Site 0067), Chicago, Illinois, United States

    Study coordinator · 773-702-6149
  • Saint Elizabeth Medical Center Edgewood-Cancer Care Center ( Site 0053), Edgewood, Kentucky, United States

    Study coordinator · 859-301-4245
  • Mary Bird Perkins Cancer Center-Breast & GYN Pavilion ( Site 0042), Baton Rouge, Louisiana, United States

    Study coordinator · 888-501-4763
  • Greenebaum Comprehensive Cancer Center ( Site 0036), Baltimore, Maryland, United States

    Study coordinator · 410-328-6373
  • Mercy Medical Center - Baltimore-Medical Oncology and Hematology ( Site 0028), Baltimore, Maryland, United States

  • Holy Cross Hospital ( Site 0073), Silver Spring, Maryland, United States

    Study coordinator · 301-754-7000
  • Dana-Farber Cancer Institute-Breast Oncology Center ( Site 0037), Boston, Massachusetts, United States

    Study coordinator · 857-215-3246
  • Henry Ford Health ( Site 0002), Detroit, Michigan, United States

    Study coordinator · 313-916-2576
  • Saint Luke's Cancer Institute ( Site 0027), Kansas City, Missouri, United States

    Study coordinator · 816-932-2677
  • Washington University School of Medicine ( Site 0076), St Louis, Missouri, United States

    Study coordinator · 314-454-8313
  • NYU Langone Health - Brooklyn ( Site 0089), Brooklyn, New York, United States

    Study coordinator · 212-731-6000
  • NYU Langone Hospital - Long Island ( Site 0090), Mineola, New York, United States

    Study coordinator · 212-731-6000
  • Laura and Isaac Perlmutter Cancer Center-Hematology and Oncology ( Site 0068), New York, New York, United States

    Study coordinator · 212-731-6000
  • Hematology Oncology Associates of Rockland ( Site 0054), Nyack, New York, United States

    Study coordinator · 845-362-1750
  • Stony Brook University-Cancer Center ( Site 0034), Stony Brook, New York, United States

    Study coordinator · 631-444-4392
  • Levine Cancer Institute ( Site 0014), Charlotte, North Carolina, United States

    Study coordinator · 980-442-2000
  • Zangmeister Cancer Center ( Site 7000), Columbus, Ohio, United States

  • Providence Portland Medical Center ( Site 0044), Portland, Oregon, United States

    Study coordinator · 503-215-2619
  • Providence St. Vincent Medical Center ( Site 0081), Portland, Oregon, United States

    Study coordinator · 503-215-2619
  • Thomas Jefferson University - Clinical Research Institute ( Site 0056), Philadelphia, Pennsylvania, United States

    Study coordinator · 215-955-8874
  • Texas Oncology-Dallas Presbyterian Hospital ( Site 8000), Dallas, Texas, United States

    Study coordinator · 214-265-2080
  • Parkland Health and Hospital System ( Site 0069), Dallas, Texas, United States

    Study coordinator · 214-590-8000
  • UT Southwestern Medical Center ( Site 0050), Dallas, Texas, United States

    Study coordinator · 214-648-3111
  • The Center for Cancer and Blood Disorders ( Site 0041), Fort Worth, Texas, United States

    Study coordinator · 817-759-7000
  • Texas Oncology - San Antonio ( Site 8002), San Antonio, Texas, United States

    Study coordinator · 212-241-0493
  • The University of Texas Health Science Center at Tyler dba UT Health East Texas HOPE Cancer Center ( Site 0057), Tyler, Texas, United States

    Study coordinator · 903-595-7093
  • Inova Schar Cancer Institute ( Site 0025), Fairfax, Virginia, United States

    Study coordinator · 571-472-4724
  • Bon Secours St. Francis Medical Center-Oncology Research ( Site 0015), Midlothian, Virginia, United States

    Study coordinator · 804-594-7300
  • VCU Health Adult Outpatient Pavillion ( Site 0070), Richmond, Virginia, United States

    Study coordinator · 877-462-7739
  • Oncology and Hematology Associates of Southwest Virginia (BRCC) ( Site 8001), Roanoke, Virginia, United States

    Study coordinator · 844-482-4812
  • University Hospital and UW Health Clinics-Carbone Cancer Center ( Site 0040), Madison, Wisconsin, United States

    Study coordinator · 800-622-8922
  • Instituto Alexander Fleming-Alexander Fleming ( Site 0382), Buenos Aires, Buenos Aires F.D., Argentina

    Study coordinator · +541132218900
  • Fundacion Estudios Clinicos-Oncology ( Site 0384), Rosario, Santa Fe Province, Argentina

    Study coordinator · +543412221472
  • Hospital Aleman-Oncology ( Site 0386), Buenos Aires, Argentina

    Study coordinator · 541148277000 #3036
  • Centro de Educación Médica e Investigaciones clínicas "Dr. Norberto Quirno" (CEMIC) ( Site 0383), Buenos Aires, Argentina

    Study coordinator · 52990100
  • Hospital Italiano de Córdoba ( Site 0385), Córdoba, Argentina

    Study coordinator · +543514106500
  • Fundación CORI para la Investigación y Prevención del Cáncer ( Site 0387), La Rioja, Argentina

    Study coordinator · 543804436443 x108
  • Macquarie University-MQ Health Clinical Trials Unit ( Site 2002), Macquarie University, New South Wales, Australia

    Study coordinator · +61298122956
  • Westmead Hospital ( Site 2000), Westmead, New South Wales, Australia

    Study coordinator · +61288905200
  • Frankston Hospital-Oncology and Haematology ( Site 2003), Frankston, Victoria, Australia

  • Fiona Stanley Hospital-Medical Oncology ( Site 2004), Murdoch, Western Australia, Australia

    Study coordinator · +61861526530
  • Institut Jules Bordet-Medicine Oncology ( Site 1104), Anderlecht, Bruxelles-Capitale, Region de, Belgium

    Study coordinator · +32 2 541 72 51
  • Cliniques universitaires Saint-Luc-Medical Oncology ( Site 1103), Brussels, Bruxelles-Capitale, Region de, Belgium

    Study coordinator · +3227645106
  • Jessa Ziekenhuis-Limburgs Oncologisch Centrum ( Site 1105), Hasselt, Limburg, Belgium

    Study coordinator · +3211337990
  • AZ Maria Middelares-IKG ( Site 1106), Ghent, Oost-Vlaanderen, Belgium

    Study coordinator · 09 246 95 23
  • Université Catholique de Louvain-Namur - Centre Hospitalier -Oncology ( Site 1107), Namur, Belgium

    Study coordinator · 3281423849
  • Oncoclínica Oncologistas Associados-Clinical Research ( Site 0407), Teresina, Piauí, Brazil

    Study coordinator · +5586999007799
  • Hospital Moinhos de Vento ( Site 0403), Porto Alegre, Rio Grande do Sul, Brazil

    Study coordinator · +555133142965
  • Hospital do Câncer Mãe de Deus ( Site 0404), Porto Alegre, Rio Grande do Sul, Brazil

    Study coordinator · +555133072943
  • Instituto de Oncologia Saint Gallen ( Site 0412), Santa Cruz do Sul, Rio Grande do Sul, Brazil

    Study coordinator · +55513056-8686
  • Instituto do Câncer Brasil - Unidade Taubaté ( Site 0408), Taubaté, São Paulo, Brazil

    Study coordinator · +551236318559
  • IBCC - Núcleo de Pesquisa e Ensino ( Site 0401), São Paulo, Brazil

    Study coordinator · +551144500300
  • BC Cancer Surrey ( Site 0315), Surrey, British Columbia, Canada

    Study coordinator · 604-930-2098
  • Southlake Health ( Site 0311), Newmarket, Ontario, Canada

  • Princess Margaret Cancer Centre ( Site 0310), Toronto, Ontario, Canada

    Study coordinator · 416-946-5605
  • CIUSSS de l'Est-de-l'Île-de-Montréal ( Site 0301), Montreal, Quebec, Canada

    Study coordinator · 514-252-3400 x5370
  • Jewish General Hospital ( Site 0303), Montreal, Quebec, Canada

    Study coordinator · 514-340-8222
  • CHU de Quebec Universite Laval - Hopital du Saint-Sacrement ( Site 0302), Québec, Quebec, Canada

    Study coordinator · 418-682-7511
  • Centre intégré de santé et de services sociaux du Bas Saint-Laurent- Hôpital régional de Rimouski ( Site 0308), Rimouski, Quebec, Canada

    Study coordinator · 418 724-3000 x8029
  • FALP-UIDO ( Site 0451), Santiago, Region M. de Santiago, Chile

    Study coordinator · +56224205098
  • Oncovida ( Site 0453), Santiago, Region M. de Santiago, Chile

    Study coordinator · 56226023875
  • Clínica RedSalud Vitacura ( Site 0455), Santiago, Region M. de Santiago, Chile

    Study coordinator · 56223954044
  • Pontificia Universidad Catolica de Chile ( Site 0454), Santiago, Region M. de Santiago, Chile

    Study coordinator · +56934331806
  • Bradfordhill ( Site 0452), Santiago, Region M. de Santiago, Chile

    Study coordinator · +56229490970
  • Bradford Hill Norte ( Site 0456), Antofagasta, Chile

    Study coordinator · 56442023631
  • Fundacion Colombiana de Cancerología Clinica Vida ( Site 0506), Medellín, Antioquia, Colombia

    Study coordinator · +57 3147362301
  • FUNDACION CTIC CENTRO DE TRATAMIENTO E INVESTIGACION SOBRE CANCER LUIS CARLOS SARMIENTO ANGULO ( Site 0507), Bogotá, Bogota D.C., Colombia

    Study coordinator · +57 6017454421x90614
  • Sociedad De Oncología y Hematología Del Cesar SAS-Oncology ( Site 0501), Valledupar, Cesar Department, Colombia

    Study coordinator · + 57 317 515 0103
  • IMAT S.A.S ( Site 0502), Montería, Departamento de Córdoba, Colombia

    Study coordinator · + 57 320 566 9416
  • Fundación Valle del Lili ( Site 0508), Cali, Valle del Cauca Department, Colombia

    Study coordinator · +576023319090 - 4022
  • CIMCA ( Site 0551), San José, Provincia de San José, Costa Rica

    Study coordinator · +50683893636
  • Hospital Metropolitano - Sede Lindora ( Site 0550), Santa Ana, Provincia de San José, Costa Rica

  • ICIMED ( Site 0552), San José, Costa Rica

    Study coordinator · +50688317449
  • Fakultni nemocnice Ostrava-Klinika onkologicka ( Site 1134), Ostrava-Poruba, Moravian-Silesian Region, Czechia

    Study coordinator · +420597372124
  • Fakultni nemocnice Olomouc-Onkologicka klinika ( Site 1132), Olomouc, Olomouc Region, Czechia

    Study coordinator · +420588444295
  • Fakultni nemocnice v Motole-Onkologicka klinika 2. LF UK a FN Motol ( Site 1136), Prague, Praha 5, Czechia

    Study coordinator · +420224434700
  • Nemocnice Ceske Budejovice-Onkologicke oddeleni ( Site 1138), České Budějovice, South Bohemian Region, Czechia

    Study coordinator · +420387875001
  • Fakultni nemocnice Kralovske Vinohrady-Onkologická klinika ( Site 1135), Prague, Czechia

    Study coordinator · +420267163562
  • Rigshospitalet ( Site 1180), Copenhagen, Capital Region, Denmark

    Study coordinator · +45 35453545
  • Nordsjællands Hospital - Hillerød ( Site 1184), Hillerød, Capital Region, Denmark

    Study coordinator · +4548294829
  • Næstved Sygehus ( Site 1182), Næstved, Region Sjælland, Denmark

    Study coordinator · +45 56512000
  • Odense Universitetshospital ( Site 1181), Odense, Region Syddanmark, Denmark

    Study coordinator · +45 66113333
  • Vejle Sygehus ( Site 1183), Vejle, Region Syddanmark, Denmark

    Study coordinator · +45 79405000
  • Hopital Prive Jean Mermoz-Oncology ( Site 1246), Lyon, Auvergne-Rhône-Alpes, France

    Study coordinator · 33437538725
  • Centre François Baclesse ( Site 1250), Caen, Calvados, France

    Study coordinator · +33231455050
  • Centre de Cancérologie du Grand Montpellier ( Site 1244), Montpellier, Languedoc-Roussillon, France

    Study coordinator · 0430298723
  • Hôpital privé du Confluent SAS-Service d'oncologie médicale ( Site 1242), Nantes, Loire-Atlantique, France

    Study coordinator · 33228272088
  • Centre Hospitalier Universitaire de Poitiers-Pôle régional de cancérologie ( Site 1243), Poitiers, Vienne, France

    Study coordinator · 33549444548
  • Pitie Salpetriere University Hospital ( Site 1249), Paris, France

    Study coordinator · 33142160097
  • Institut Curie-Oncology medical Department ( Site 1240), Paris, France

    Study coordinator · +33144324675
  • Universitaetsklinikum Erlangen-Klinik für Gynäkologie und Geburtshilfe ( Site 1301), Erlangen, Bavaria, Germany

    Study coordinator · +4991318533572
  • Klinikum Ernst von Bergmann-Frauenklinik ( Site 1305), Potsdam, Brandenburg, Germany

    Study coordinator · +493312415602
  • Franziskus-Hospital Harderberg ( Site 1308), Georgsmarienhütte, Lower Saxony, Germany

    Study coordinator · +495415022466
  • Universitaetsklinikum Duesseldorf-Klinik für Frauenheilkunde & Geburtshilfe ( Site 1311), Düsseldorf, North Rhine-Westphalia, Germany

    Study coordinator · +492118117506
  • Kliniken Essen-Mitte, Evangelische Huyssens-Stiftung-Klinik für Senologie/ Brustzentrum ( Site 1300), Essen, North Rhine-Westphalia, Germany

    Study coordinator · +4920117433005
  • CaritasKlinikum Saarbruecken St. Theresia ( Site 1304), Saarbrücken, Saarland, Germany

    Study coordinator · +496814061345
  • SRH Wald-Klinikum Gera-Zentrum für klinische Studien ( Site 1315), Gera, Thuringia, Germany

    Study coordinator · +493658287758
  • Helios Klinikum Berlin-Buch-Klinik für Gynäkologie und Geburtshilfe ( Site 1314), Berlin, Germany

    Study coordinator · +4930940113394
  • Errikos Dunant Hospital Center ( Site 1348), Athens, Attica, Greece

    Study coordinator · +302106972433
  • Aretaieio Hospital Oncology Unit ( Site 1345), Athens, Attica, Greece

    Study coordinator · +302107286444
  • Hygeia Hospital ( Site 1346), Marousi, Attica, Greece

    Study coordinator · +302106867165
  • University General Hospital of Larissa ( Site 1343), Larissa, Thessaly, Greece

    Study coordinator · +302413502785
  • St. LUKE'S HOSPITAL S.A. ( Site 1347), Thessaloniki, Greece

    Study coordinator · +302310390671
  • European Interbalkan Medical Center ( Site 1341), Thessaloniki, Greece

    Study coordinator · +302313252011
  • Queen Mary Hospital ( Site 2040), Hksar, Hong Kong

    Study coordinator · QMH- +852 2255 3838
  • Prince of Wales Hospital ( Site 2041), Shatin, Hong Kong

    Study coordinator · +852 3505 2211
  • Szegedi Tudományegyetem Szent-Györgyi Albert Klinikai Központ-Onkoterápiás Klinika ( Site 1379), Szeged, Csongrád megye, Hungary

    Study coordinator · 3662545404
  • Somogy Vármegyei Kaposi Mór Oktató Kórház-Oncology center ( Site 1371), Kaposvár, Somogy County, Hungary

    Study coordinator · 36304111268
  • Zala Vármegyei Szent Rafael Kórház-Onkológiai osztály ( Site 1372), Zalaegerszeg, Zala County, Hungary

    Study coordinator · 36304199969
  • Semmelweis Egyetem-Belgyógyászati és Onkológiai Klinika ( Site 1381), Budapest, Hungary

    Study coordinator · 36208258821
  • Budapesti Uzsoki Utcai Kórház-Onkoradiológiai Osztály ( Site 1373), Budapest, Hungary

    Study coordinator · +36209674709
  • Debreceni Egyetem Klinikai Kozpont-Onkológiai Klinika ( Site 1375), Debrecen, Hungary

    Study coordinator · +3652255585
  • Tata Memorial Hospital-Medical Oncology ( Site 2053), Mumbai, Maharashtra, India

    Study coordinator · 9967111418
  • Kokilaben Dhirubhai Ambani Hospital & Medical Research Institute-Centre for cancer ( Site 2056), Mumbai, Maharashtra, India

  • All India Institute of Medical Sciences ( Site 2051), New Delhi, National Capital Territory of Delhi, India

    Study coordinator · 504326588500
  • Rajiv Gandhi Cancer Institute And Research Centre-Department of Clinical Research ( Site 2052), New Delhi, National Capital Territory of Delhi, India

    Study coordinator · 8005328138
  • Bon Secours Cork Hospital ( Site 1422), Cork, Ireland

    Study coordinator · +353214542807
  • St. Vincent's University Hospital-Medical Oncology Research Department ( Site 1420), Dublin, Ireland

    Study coordinator · +353012214000
  • Mater Misericordiae University Hospital-Clinical Trials Research Unit ( Site 1423), Dublin, Ireland

    Study coordinator · +353018034834
  • Rambam Health Care Campus-Oncology Division ( Site 1452), Haifa, Israel

    Study coordinator · 04-7776234
  • Hadassah Medical Center ( Site 1451), Jerusalem, Israel

    Study coordinator · 02-6777111
  • Rabin Medical Center ( Site 1453), Petah Tikva, Israel

    Study coordinator · 039378076
  • Sheba Medical Center ( Site 1450), Ramat Gan, Israel

    Study coordinator · +972-35304436
  • IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori" ( Site 1480), Meldola, Forli-Cesena, Italy

    Study coordinator · +390543739100
  • CRO-IRCCS ( Site 1478), Aviano, Friuli Venezia Giulia, Italy

    Study coordinator · +39 0434659514
  • Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 1472), Milan, Lombardy, Italy

    Study coordinator · +390223902849
  • Istituto Europeo di Oncologia IRCCS-Divisione di Senologia Medica ( Site 1475), Milan, Lombardy, Italy

    Study coordinator · +02 57489970
  • Istituto Clinico Humanitas ( Site 1476), Rozzano, Milano, Italy

    Study coordinator · +390282244080
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola ( Site 1474), Bologna, Italy

    Study coordinator · +39 0512144548
  • Ospedale San Martino ( Site 1479), Genova, Italy

    Study coordinator · +390105600387
  • Ospedale San Raffaele-Oncologia Medica ( Site 1471), Milan, Italy

    Study coordinator · +390226436530
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore ( Site 1477), Roma, Italy

    Study coordinator · +3930156318
  • Nagoya City University Hospital ( Site 2474), Nagoya, Aichi-ken, Japan

    Study coordinator · +81-52-858-7215
  • National Cancer Center Hospital East ( Site 2463), Kashiwa, Chiba, Japan

    Study coordinator · +81-4-7133-1111
  • Hokkaido University Hospital ( Site 2460), Sapporo, Hokkaido, Japan

    Study coordinator · +81-11-716-1161
  • Tokai University Hospital ( Site 2473), Isehara, Kanagawa, Japan

    Study coordinator · +81-463-93-1121
  • St. Marianna University Hospital ( Site 2465), Kawasaki, Kanagawa, Japan

    Study coordinator · +81-44-977-8111
  • Kitasato University Hospital ( Site 2471), Sagamihara, Kanagawa, Japan

    Study coordinator · +81-42-778-9965
  • Kanagawa Cancer Center ( Site 2472), Yokohama, Kanagawa, Japan

    Study coordinator · +81-45-520-2222
  • Mie University Hospital ( Site 2483), Tsu, Mie-ken, Japan

    Study coordinator · +81-59-231-5246
  • Tohoku University Hospital ( Site 2482), Sendai, Miyagi, Japan

    Study coordinator · +81-22-717-7000
  • The University of Osaka Hospital ( Site 2476), Suita, Osaka, Japan

    Study coordinator · +81-6-6210-8290
  • Saitama Medical University International Medical Center ( Site 2462), Hidaka, Saitama, Japan

    Study coordinator · +81-42-984-4111
  • Juntendo University Hospital ( Site 2468), Bunkyo, Tokyo, Japan

    Study coordinator · +81-3-3813-3111
  • Cancer Institute Hospital of JFCR ( Site 2464), Koto, Tokyo, Japan

    Study coordinator · +81-3-3520-0111
  • Showa Medical University Hospital ( Site 2466), Shinagawa, Tokyo, Japan

    Study coordinator · +81-3-3784-8000
  • Tokyo Medical University Hospital ( Site 2467), Shinjuku, Tokyo, Japan

    Study coordinator · +81-3-3342-6111
  • National Center for Global Health and Medicine ( Site 2469), Shinjuku, Tokyo, Japan

    Study coordinator · +81-3-3202-7181
  • Fukushima Medical University Hospital ( Site 2461), Fukushima, Japan

    Study coordinator · +81-24-547-1111
  • Gifu University Hospital ( Site 2486), Gifu, Japan

    Study coordinator · +81-58-230-6000
  • Hiroshima City Hiroshima Citizens Hospital ( Site 2478), Hiroshima, Japan

    Study coordinator · +81-82-221-2291
  • Social medical corporation Hakuaikai Sagara Hospital ( Site 2481), Kagoshima, Japan

    Study coordinator · +81-99-224-1800
  • Kumamoto University Hospital ( Site 2480), Kumamoto, Japan

    Study coordinator · +81-96-344-2111
  • Kyoto University Hospital ( Site 2475), Kyoto, Japan

    Study coordinator · +81-75-751-4389
  • Okayama University Hospital ( Site 2485), Okayama, Japan

    Study coordinator · +81-86-223-7151
  • Osaka Prefectural Hospital Organization Osaka International Cancer Institute ( Site 2477), Osaka, Japan

    Study coordinator · +81-6-6945-1181
  • Hospital Sultan Ismail ( Site 2153), Johor Bahru, Johor, Malaysia

    Study coordinator · +6073565155
  • Sarawak General Hospital ( Site 2154), Kuching, Sarawak, Malaysia

    Study coordinator · +6082276820
  • Pantai Hospital Kuala Lumpur ( Site 2151), Kuala Lumpur, Malaysia

    Study coordinator · +60327814519
  • CIO - Centro de Inmuno-Oncología de Occidente ( Site 0592), Guadalajara, Jalisco, Mexico

    Study coordinator · +523332592394
  • Grupo Médico ASSET-Clinical Research ( Site 0596), Mexico City, Mexico City, Mexico

    Study coordinator · +52155551013316
  • Health Pharma Professional Research S.A. de C.V: ( Site 0598), Mexico City, Mexico City, Mexico

    Study coordinator · +525575864856
  • INCAN-TUMORES MAMARIOS ( Site 0597), Mexico City, Mexico City, Mexico

    Study coordinator · +52 55 5451 4847
  • Hospital Universitario "Dr. Jose Eleuterio Gonzalez"-Servicio de Oncología ( Site 0590), Monterrey, Nuevo León, Mexico

  • CENTRO MEDICO ZAMBRANO HELLION-Centro de Cáncer de Mama ( Site 0595), San Pedro Garza García, Nuevo León, Mexico

  • Ziekenhuis Rijnstate-Rijnstate Centrum Oncologisch Onderzoek ( Site 1524), Arnhem, Gelderland, Netherlands

    Study coordinator · +31880056201
  • Maastricht UMC+-Medical Oncology ( Site 1522), Maastricht, Limburg, Netherlands

    Study coordinator · +31433877025
  • Amphia Ziekenhuis, locatie Breda Molengracht-oncologie ( Site 1523), Breda, North Brabant, Netherlands

    Study coordinator · +31765952408
  • Catharina Ziekenhuis ( Site 1526), Eindhoven, North Brabant, Netherlands

    Study coordinator · +31402396622
  • Nederlands Kanker Instituut - Antoni van Leeuwenhoek (NKI-AVL)-medical oncology ( Site 1520), Amsterdam, North Holland, Netherlands

    Study coordinator · +31205129111
  • Isala, locatie Zwolle ( Site 1525), Zwolle, Overijssel, Netherlands

    Study coordinator · +31886246040
  • Meander Medisch Centrum ( Site 1521), Amersfoort, Utrecht, Netherlands

    Study coordinator · +31338507278
  • Auckland City Hospital ( Site 2031), Auckland, New Zealand

  • Clinica Vallesur - AUNA ( Site 0652), Arequipa, Ariqipa, Peru

  • Hospital Militar Central Luis Arias Schereiber ( Site 0651), Jesús María, Lima, Peru

  • Oncosalud ( Site 0650), Lima, Muni Metro de Lima, Peru

  • IPOR Instituto Peruano de Oncología & Radioterapia ( Site 0653), Lima, Peru

  • Metro Davao Medical and Research Center ( Site 2202), Davao City, Davao Del Sur, Philippines

    Study coordinator · (082) - 287-7777
  • ST. LUKE'S MEDICAL CENTER-Medicine ( Site 2200), Quezon City, National Capital Region, Philippines

    Study coordinator · 09498889607
  • Centrum Onkologii im. Prof. Franciszka Lukaszczyka-Ambulatorium Chemioterapii ( Site 1582), Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland

    Study coordinator · +48523743525
  • Mazowiecki Szpital Wojewódzki w Siedlcach-Siedleckie Centrum Onkologii ( Site 1584), Siedlce, Masovian Voivodeship, Poland

    Study coordinator · +4825640372
  • Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworów Piersi i Chirurgii ( Site 1580), Warsaw, Masovian Voivodeship, Poland

    Study coordinator · +48225462000
  • Mazowiecki Szpital Onkologiczny ( Site 1581), Wieliszew, Masovian Voivodeship, Poland

  • Mrukmed-Mrukmed ( Site 1592), Rzeszów, Podkarpackie Voivodeship, Poland

    Study coordinator · +48178530728
  • Bialostockie Centrum Onkologii ( Site 1585), Bialystok, Podlaskie Voivodeship, Poland

    Study coordinator · +48856646888
  • Szpitale Pomorskie Sp. z o. o.-Oddział Onkologii Klinicznej ( Site 1593), Gdynia, Pomeranian Voivodeship, Poland

  • Narodowy Instytut Onkologii - Oddzial w Gliwicach-Centrum Diagnostyki i Leczenia Chorob Piersi ( Site 1590), Gliwice, Silesian Voivodeship, Poland

    Study coordinator · +48322788721
  • Szpital Wojewódzki w Koszalinie. ( Site 1583), Poland, West Pomeranian Voivodeship, Poland

  • Zachodniopomorskie Centrum Onkologii ( Site 1588), Szczecin, West Pomeranian Voivodeship, Poland

  • Swietokrzyskie Centrum Onkologii, Samodzielny Publiczny Zakl-Klinika Onkologii Klinicznej, Dzial Ch ( Site 1595), Kielce, Świętokrzyskie Voivodeship, Poland

  • Unidade Local de Saude Amadora/Sintra - Hospital Prof Dr Fernando Fonseca ( Site 1663), Lisbon, Lisbon District, Portugal

    Study coordinator · 00351214348200
  • Unidade Local de Saude de Santa Maria - Hospital de Santa Maria ( Site 1661), Lisbon, Portugal

    Study coordinator · 00351217805000
  • Instituto Português de Oncologia do Porto Francisco Gentil, EPE ( Site 1662), Porto, Portugal

    Study coordinator · 00351225084000
  • Puerto Rico Medical Research Center LLC ( Site 0675), Hato Rey, Puerto Rico

  • UPR Comprehensive Cancer Center-Comprehensive Cancer Center Hospital ( Site 0677), San Juan, Puerto Rico

    Study coordinator · 7877728300 Ext 1226
  • Spitalul Clinic Filantropia ( Site 1703), Bucharest, Bucharest, Romania

    Study coordinator · 0040213188930
  • SC Radiotherapy Center Cluj SRL-Oncologie Medicala ( Site 1702), Florești, Cluj, Romania

    Study coordinator · 0040219368
  • Centrul Medical Neolife- Baneasa ( Site 1704), Bucharest, Romania

    Study coordinator · 0040217948731
  • Institutul Oncologic Cluj ( Site 1701), Cluj-Napoca, Romania

    Study coordinator · 0040264598362
  • National University Hospital ( Site 2250), Singapore, Central Singapore, Singapore

    Study coordinator · +6569082222
  • Mount Alvernia ICON Cancer Center ( Site 2251), Singapore, North East, Singapore

    Study coordinator · +6562550528
  • CANCERCARE LANGENHOVEN DRIVE ONCOLOGY CENTRE ( Site 2905), Port Elizabeth, Eastern Cape, South Africa

    Study coordinator · 041 450 6152
  • Wits Clinical Research ( Site 2903), Johannesburg, Gauteng, South Africa

    Study coordinator · +27113390600
  • Curo Oncology ( Site 2908), Pretoria, Gauteng, South Africa

    Study coordinator · +27123356771
  • Sandton Oncology Medical Group (Pty) Ltd ( Site 2911), Sandton, Gauteng, South Africa

    Study coordinator · +27118830900
  • Cancercare Rondebosch Oncology-Clinical trials ( Site 2904), Cape Town, Western Cape, South Africa

    Study coordinator · +279443700
  • Seoul National University Hospital-Internal Medicine ( Site 2353), Seoul, South Korea

  • Severance Hospital, Yonsei University Health System-Medical oncology ( Site 2350), Seoul, South Korea

    Study coordinator · 82222288135
  • Asan Medical Center-Department of Oncology ( Site 2352), Seoul, South Korea

    Study coordinator · +82230105397
  • Samsung Medical Center-Division of Hematology/Oncology ( Site 2351), Seoul, South Korea

    Study coordinator · 82234106833
  • HOSPITAL UNIVERSITARIO QUIRONSALUD MADRID ( Site 1758), Pozuelo de Alarcón, Madrid, Spain

    Study coordinator · +34914521987
  • HOSPITAL CLINICO DE VALENCIA-Oncology ( Site 1752), Valencia, Valenciana, Comunitat, Spain

    Study coordinator · +34961973583
  • Hospital Universitari Vall d'Hebron-Oncology ( Site 1750), Barcelona, Spain

    Study coordinator · +34932746000
  • Hospital Universitario Reina Sofia-Oncologia Medica ( Site 1754), Córdoba, Spain

    Study coordinator · +34957511464
  • Hospital Beata María Ana-oncology ( Site 1755), Madrid, Spain

    Study coordinator · +34914097423
  • HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑON-ONCOLOGY ( Site 1756), Madrid, Spain

    Study coordinator · +3491 426 93 92
  • Hospital Universitario Virgen Macarena ( Site 1757), Seville, Spain

    Study coordinator · +34955008000
  • Karolinska Universitetssjukhuset Solna ( Site 1801), Stockholm, Stockholm County, Sweden

    Study coordinator · +46812370000
  • Akademiska sjukhuset ( Site 1802), Uppsala, Uppsala County, Sweden

    Study coordinator · +46186110000
  • Södra Älvsborgs Sjukhus Borås ( Site 1803), Borås, Västra Götaland County, Sweden

    Study coordinator · +46336161000
  • University Hospital Basel-Gynecology & Gynecologic Oncology ( Site 1844), Basel, Canton of Basel-City, Switzerland

    Study coordinator · +41613284214
  • Spital Thun ( Site 1840), Thun, Canton of Bern, Switzerland

    Study coordinator · +41 58 636 22 27
  • Brust-Zentrum ( Site 1841), Zurich, Canton of Zurich, Switzerland

    Study coordinator · +41 44 533 81 05
  • Changhua Christian Hospital ( Site 2410), Changhua, Taiwan

  • Chang Gung Memorial Hospital at Kaohsiung-Oncology and Hematology ( Site 2413), Kaohsiung City, Taiwan

    Study coordinator · +88677317123x3267
  • National Cheng Kung University Hospital-Surgery ( Site 2411), Tainan, Taiwan

    Study coordinator · +88662353535
  • National Taiwan University Hospital-Oncology ( Site 2415), Taipei, Taiwan

    Study coordinator · 886-2-23123456x71673
  • Mackay Memorial Hospital ( Site 2412), Taipei, Taiwan

    Study coordinator · +886225433535
  • Chang Gung Medical Foundation-Linkou Branch-General Surgery ( Site 2414), Taoyuan, Taiwan

    Study coordinator · +88633281200x3219
  • Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastırma Hastanesi ( Site 1878), Yenimahalle, Ankara, Turkey (Türkiye)

    Study coordinator · 0090 506 366 5181
  • Medipol Mega Universite Hastanesi-oncology ( Site 1875), Stanbul, Istanbul, Turkey (Türkiye)

    Study coordinator · 4447044
  • Adana Medical Park Seyhan Hastanesi-Medikal Onkoloji ( Site 1876), Adana, Turkey (Türkiye)

    Study coordinator · 905056166338
  • Hacettepe Universite Hastaneleri-oncology hospital ( Site 1870), Ankara, Turkey (Türkiye)

    Study coordinator · +903123054330 (9264)
  • Memorial Ankara Hastanesi-Medical Oncology ( Site 1874), Ankara, Turkey (Türkiye)

    Study coordinator · 00905067521275
  • Ankara Bilkent Şehir Hastanesi-Medical Oncology ( Site 1871), Ankara, Turkey (Türkiye)

    Study coordinator · +903125526000/622111
  • TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 1872), Istanbul, Turkey (Türkiye)

  • Samsun Medical Park Hastanesi-medical oncology ( Site 1873), Samsun, Turkey (Türkiye)

    Study coordinator · +90 362 311 40 40
  • North West Cancer Centre ( Site 1944), Londonderry, Derry and Strabane, United Kingdom

    Study coordinator · 02871320781
  • The Royal Cornwall Hospital ( Site 1943), Truro, England, United Kingdom

    Study coordinator · +441872258343
  • St Bartholomew's Hospital-Centre for Experimental Cancer Medicine ( Site 1940), London, London, City of, United Kingdom

    Study coordinator · 1-888-577-8839
  • University College London Hospital-Cancer Clinical Trials Unit ( Site 1942), London, London, City of, United Kingdom

    Study coordinator · 1-888-577-8839
  • Blackpool Victoria Hospital ( Site 1941), Blackpool, United Kingdom

    Study coordinator · 01253 951524
  • City Hospital, Nottingham University Hospitals NHS Trust ( Site 1945), Nottingham, United Kingdom

    Study coordinator · 441159691169
מובילי המחקר
  • Medical Director

    Study Director

    Merck Sharp & Dohme LLC